---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-25-011825"
form_type: "8-K/A"
ticker: "NDRA"
cik: "0001681682"
company_name: "ENDRA Life Sciences Inc."
filed_at: "2025-10-15T23:59:59+00:00"
generated_at: "2026-05-17T03:45:09.412018+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ENDRA raises $4.9M in private placement to launch digital asset treasury strategy

## Summary
- Sold 744,340 shares/pre-funded warrants plus up to 1,488,680 common warrants at $6.57 per unit; $6.81 for director participant.
- Gross proceeds ~$4.9M; up to $14.4M if common warrants exercised; majority allocated to digital asset treasury (DAT) strategy.
- Engaged Arca Investment Management to manage $3.5M of DAT assets; fees 1.25–1.75% AUM + 10–15% performance fee; issued 400,000 advisory warrants.
- Terminated at-the-market equity facility with Ascendiant effective October 13, 2025.
- 2025 annual meeting set for December 9, 2025; record date October 16, 2025; stockholder proposal deadline October 27, 2025.

## SEC filing metadata
- accession: 0001654954-25-011825
- form_type: 8-K/A
- ticker: NDRA
- cik: 0001681682
- company_name: ENDRA Life Sciences Inc.
- filed_at: 2025-10-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 1.02, 3.02, 5.08, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1681682/000165495425011825/0001654954-25-011825-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1681682/000165495425011825/endra_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-25-011825
- JSON: https://secwatch.observer/filing/0001654954-25-011825.json
- Plain text: https://secwatch.observer/filing/0001654954-25-011825.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.